^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    GD2-CART

    i
    Other names: GD2-CART, GD2 CAR T, GD2CART
    Associations
    News
    Trials
    Company:
    Stanford University
    Drug class:
    GD2-targeted CAR-T immunotherapy
    Related drugs:
    Associations
    News
    Trials